Data from in vitro and animal experiments suggest that progressive endothelial damage with subsequent activation of coagulation and inflammation have a key role in hypertensive crisis. However, clinical investigations are scarce. We hypothesized that hypertensive emergencies are associated with enhanced inflammation, endothelial-and coagulation activation. Thus, we enrolled 60 patients admitted to an emergency department in a prospective, cross-sectional study. We compared markers of coagulation, fibrinolysis (prothrombin fragment F 1 þ 2 , plasmin-antiplasmin complexes, plasmin-activator inhibitor, tissue plasminogen activator), platelet-and endothelial activation and inflammation (P-selectin, C-reactive protein, leukocyte counts, fibrinogen, soluble vascular adhesion molecule-1, intercellular adhesion molecule-1, myeloperoxidase and asymmetric dimethylarginine) between hypertensive emergencies, urgencies and normotensive patients. In hypertensive emergencies, markers of inflammation and endothelial activation were significantly higher as compared with urgencies and controls (Po0.05). Likewise, plasmin-antiplasmin complexes were 75% higher in emergencies as compared with urgencies (Po0.001), as were tissue plasminogen-activator levels (B30%; Po0.05) and sP-selectin (B40%; Po0.05). In contrast, similar levels of all parameters were found between urgencies and controls. We consistently observed elevated markers of thrombogenesis, fibrinolysis and inflammation in hypertensive emergencies as compared with urgencies. Further studies will be needed to clarify if these alterations are cause or consequence of target organ damage.
INTRODUCTION
Hypertensive crises are frequently observed medical events. 1, 2 They comprise critical elevation of blood pressure (BP) complicated by target organ dysfunction, defined as hypertensive emergency (HE) or without target organ deterioration, that is, hypertensive urgency (HU). 3 The endothelium has a central role in BP homeostasis and therefore in the pathogenesis of hypertensive crisis. 4 The initial triggering mechanisms are incompletely understood. It is assumed that hypertensive crisis has multifactorial causes so that mechanical injury, activation of the renin-angiotensin system, oxidative stress and production of inflammatory cytokines together lead to endothelial damage. 4 Subsequently, endothelial cells release vasodilator molecules, such as nitric oxide. 4, 5 However, when compensatory mechanisms are overwhelmed, a vicious cycle begins and progressive endothelial damage causes further rise in BP, increased endothelial permeability, activation of the coagulation system, inhibition of local fibrinolysis and production of inflammatory cytokines. 4, 5 These mechanisms can culminate in end organ hypoperfusion, ischemia and dysfunction. 4, 5 Most of the data supporting the pathophysiological concept are gained from in vitro and animal experiments, 4 and clinical investigations are scarce. Only data from patients with malignant hypertension, which is a special form of hypertensive crisis characterized by thrombotic microangiopathy and ischemic retinal changes, were recently presented. 6, 7 Thus, we set out to investigate if hypertensive emergencies are as well associated with endothelial or coagulation activation and inflammation. We further wanted to investigate if this occurs to a lesser extent in hypertensive urgencies without target organ deterioration.
We therefore prospectively compared markers of inflammatory activity, coagulation, platelet and endothelial activation and fibrinolysis between patients with hypertensive emergencies and urgencies treated at a non-surgical emergency department (ED). Normotensive patients, attending the ED for other reasons, served as an additional control group.
MATERIALS AND METHODS

Study population
The study was approved by the local Ethics Committee and was carried out at the non-surgical ED of the Medical University of Vienna, a tertiary care center, from 2008 to 2009, according to the Declaration of Helsinki.
After written informed consent, 60 patients were enrolled in this cross-sectional study-20 consecutive patients with hypertensive emergencies and 20 with hypertensive urgency. Twenty age-matched normotensive patients, who attended the ED for other reasons (gastritis (n ¼ 2), back pain (n ¼ 8), needlestick injury (n ¼ 1), follow-up after needlestick injury (n ¼ 8), electric shock (n ¼ 1)), served as an additional control group.
HE and HU were defined according to the guidelines 3 as follows: elevation of BP X180 mm Hg systolic and/or X110 mm Hg diastolic without evidence of target organ deterioration (that is, HU). HE was defined as severe BP elevation (s. above) with target organ dysfunction (acute pulmonary edema, coronary ischemia, hypertensive encephalopathy, cerebral infarction, intracerebral hemorrhage, aortic dissection or acute renal failure defined, according to the RIFLE criteria.
acute infection (that is, initial elevation of C-reactive protein 410 mg dl À 1 or fibrinogen 4450 mg dl À 1 ), acute thromboembolic disorders (pulmonary embolism, deep vein thrombosis), cancer, pre-existent therapy with oral anticoagulants and known chronic kidney disease stage 3 or higher.
Normotensive controls had no history of hypertension, no intake of antihypertensive drugs and a BP o130/85 (measured twice after 5 min of sitting in resting position), no history of diabetes mellitus, pre-existent cardiovascular disease or relevant medical illness.
BP was measured repeatedly within the scope of an ambulant or intermediate care ED setting with an automated device (Hewlett-Packard, Palo Alto, CA, USA) or within the intensive care setting via direct intraarterial measurement.
Blood was sampled before any relevant intervention; all diagnostictherapeutic interventions were performed thereafter under the discretion of the attending physician. A second independent physician, blinded to the primary clinical diagnosis, confirmed the final diagnosis (HE, HU) by chart review.
Blood was sampled into evacuated sterile tubes (Vacutainer, BD, NJ, USA). For the analysis of coagulation and inflammatory parameters, blood was immediately centrifuged at 3000 Â g for 15 min and stored as 0.5 ml aliqots at À 80 1C until batch analysis. Blood cell counts (Coulter Counter, Beckman Coulter, Brea, CA, USA) and analysis of C-reactive protein (CRP; and fibrinogen (STA, Roche Diagnostics, Vienna, Austria) were done in the central laboratory within the scope of routine laboratory assessment.
Inflammatory parameters and markers of endothelial dysfunction
Soluble vascular adhesion molecule (sVCAM)-1, soluble intercellular adhesion molecule (sICAM)-1 and myeloperoxidase (MPO) were measured by ELISA (R&D Systems, Abingdon, UK). 9 Asymmetric dimethylarginine (ADMA) was measured by high-performance liquid chromatography, as previously described. 10 
Coagulation parameters
The following parameters were measured by ELISA: Plasmin-antiplasmin complex (PAP; Enzygnost PAP micro, Behring, FRA), 11 prothrombin fragment 1 þ 2 (F 1 þ 2, Behring, FRA), 12 active plasminogen-activator inhibitor (Technozym PAI-1 Actibind,Technoclone, Vienna, Austria), tissue plasminogen-activator antigen (t-PA Ag), which detects the total amount of t-PA, and active t-PA, which is not complexed to PAI-1 (t-PA Combi Actibind, Technoclone), soluble (s) P-selectin (R&D Systems). 13 
Statistical analysis
Because of the lack of data in patients with hypertensive crisis, a sample size calculation was difficult to perform. In a study comparing CRP levels between normotensives and patients with non dipping essential hypertension, 10 patients in each group would have sufficed to provide 80% power.
14 The primary comparison in our study was between HE and HU. However, no data about HE and HU were available. Hence, we assumed that 20 persons in each group are adequate to have 80% power (a-error of 5%) to detect differences in the primary outcome variable (CRP).
Continuous data are given as median and range, if not otherwise specified, categorical data as frequencies and percentages. Categorical data were compared with the Fisher's exact test. For continuous data non parametric tests were applied. The Kruska Wallis ANOVA and the Mann-Whitney U-test were used for comparison between groups. The Spearman's correlation was used to measure correlation between parameters (SPSS 10.0, SPSS Inc., USA). Markers of coagulation, fibrinolysis, platelet activation and inflammation are interdependent. Yet, we applied the Bonferroni-Holm procedure to account for multiple comparisons. 15 
RESULTS
Demographic and clinical data are depicted in Table 1 . Twenty patients with hypertensive urgencies, 19 with emergencies and 20 normotensive control patients were finally analyzed. One patient with HE had to be excluded because of incorrectly processed blood samples.
There were no significant differences in age, body mass index, smoking habits or sex distribution between groups ( Table 1) . Use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, as well as aspirin and clopidogrel, was similar in both patient groups (Table 1 ). There were significantly more patients with diabetes in the emergency group as compared with patients with urgencies (Po0.05).
As expected, initial BP was significantly higher in HE as compared with HU (Po0.05) and pulmonary edema was the most frequent kind of end organ damage observed in HE (58%), followed by hemorrhagic stroke (26%). HU patients presented with malaise (n ¼ 2), vertigo (n ¼ 5), palpitations (n ¼ 1), headache (n ¼ 5), dizziness (n ¼ 4) and discomfort in the chest (n ¼ 3).
Markers of inflammation and endothelial activation
In patients with hypertensive emergencies, CRP was Btwofold higher as compared with urgencies (P ¼ 0.01) and 64% higher than in normotensive controls (P ¼ 0.01, Figure 1 , Table 2 ). Leukocyte counts were significantly increased in HE compared with HU and controls (Po0.001 for HE vs HU and normotensives) as were fibrinogen levels (P ¼ 0.03 HE vs HU and P ¼ 0.01 HE vs normotensives, respectively). Concentrations of both biomarkers were not significantly different between HU and normotensive patients (P ¼ n.s., Figure 1 ).
VCAM-1 levels were significantly higher in HE patients as compared with HU (P ¼ 0.01) and normotensives (P ¼ 0.01), whereas VCAM-1 was not significantly different between HU and normotensives (P ¼ 0.50, Table 2 ). No significant difference was observed for ICAM-1 levels for all groups (P ¼ 0.92 HE vs HU; P ¼ 0.08 HE and P ¼ 0.77 HU vs normotensives, respectively).
Patients with HE exhibited 26% higher MPO levels as compared with HU (P ¼ 0.05), whereas MPO levels were not significantly different between HE and normotensive patients (P ¼ 0.08 HE vs controls and P ¼ 0.54 HU vs controls, Table 2 ).
ADMA levels were significantly higher in HE as compared with HU (P ¼ 0.03), whereas there was no significant difference between crisis patients and normotensives (P ¼ 0.72 HE and 0.07 HU vs normotensives, respectively; Table 2 ).
Markers of coagulation, fibrinolysis and platelet activation F 1 þ 2 levels were only 23% higher in hypertensive emergencies as compared with urgencies, (P ¼ 0.69). However, F 1 þ 2 levels were 40% higher in HE patients as compared with normotensive controls (Po0.05), whereas no significant difference was observed between HU and normotensives ( Figure 2) . PAP levels were 75 and 47% higher in HE patients as compared with urgencies or normotensives, respectively (Po0.001 for both comparisons, Figure 2 ). Again, there was no significant difference in PAP between HU and normotensive patients (Figure 2) . PAI-1 levels were 66% higher in hypertensive emergencies and 25% higher in urgencies as compared with normotensives, which, however, was not statistically significant ( Figure 2) . Patients with HE exhibited 29% higher t-PA Ag levels than patients with urgencies and 43% higher t-PA Ag levels than controls (Po0.05 for both comparisons, Figure 2 ). Active t-PA levels were about twofold higher in HE as compared with HU or normotensives (Po0.05 HE vs HU and normotensives, Table 2 ). As seen with the other markers, there was no significant difference between HU and controls in either t-PA Ag or active t-PA ( Figure 2 , Table 2 ).
P-selectin was 42% higher in patients with HE as compared with urgencies (Po0.05) and 61% higher than in normotensives (Po0.05, Table 2 ). No significant difference in P-selectin was observed between HU and normotensive controls ( Table 2) .
Four HE patients had diabetes mellitus as compared with none in the HU group (Po0.05). After exclusion of diabetes patients, CRP, leukocyte counts, MPO, PAP and fibrinogen levels remained significantly different, whereas P-selectin and ADMA reached only borderline significance (P ¼ 0.06 for P-selectin and ADMA) and t-PA and VCAM-1 showed no significant difference (P ¼ 0.13).
Inflammation, coagulation and fibrinolysis in hypertensive crisis U Derhaschnig et al Correlation analysis was performed with systolic BP (SBP) and biochemical markers. It revealed a weak correlation between SBP and leukocyte counts (r ¼ 0.28), fibrinogen (r ¼ 0.32), PAP (r ¼ 0.43), P-selectin (r ¼ 0.31), sICAM-1 (r ¼ 0.27) and sVCAM-1 (r ¼ 0.36) ( Table 3 ). Subgroup analysis showed weak correlation of SBP and active t-PA (r ¼ 0.60) and P-selectin (r ¼ 0.55) in normotensives, SBP and fibrinogen (r ¼ 0.50) in the HU group (Table 3) . No significant correlations were found in the HE group (Table 3) .
DISCUSSION
The main findings of our study are that hypertensive emergencies, that is BP elevation with target organ damage, are associated with inflammation, coagulation and platelet activation and enhanced fibrinolytic activity. In contrast, patients with hypertensive urgencies show levels of biomarkers similar to normotensive controls.
Endothelial cells exist in a dynamic state and respond to alterations in the level of shear stress and various stimuli by induction of different genes and release of various factors. 16, 17 They release pro-inflammatory cytokines in response to mechanical stretching and angiotensin II. 4 It was recently shown that hsCRP levels were elevated in hypertensive crisis and declined after the acute event. 18 This finding was confirmed by our trial and we could additionally show increased fibrinogen and leukocyte counts in patients with HE, reflecting heightened inflammatory activity. Patients with increased CRP levels have impaired vasoreactivity, which might contribute to HE. 19, 20 Moreover, CRP itself decreases eNOS expression and induces adhesion molecule expression. 20 Soluble VCAM-1 levels were higher in our patients with HE, whereas sICAM-levels were similar to controls. Although alterations of both adhesion molecules are reported in essential hypertension, 21, 22 our results are in accordance with the data from malignant hypertension, where no difference was found in sICAM-1 levels compared with controls. 23 Shear stress induces the expression of adhesion molecules in vitro, 24 and increased expression of adhesion molecules, as observed in HE, can contribute to consecutive loss of endothelial function by promoting local inflammation. 4 MPO is a biomarker of inflammation and oxidative stress produced by neutrophils, monocytes and endothelial cells. 25 It contributes to vascular inflammation by depletion of vascular NO with ensuing endothelial dysfunction. 25 MPO is elevated in preeclampsia, strongly related to endothelial dysfunction 26 and associated with risk of cardiovascular disease. 21 ADMA is an endogenous modulator for endothelial dysfunction and oxidative stress, and increased shear stress triggers ADMA synthesis. 27 We found significantly higher MPO and ADMA levels in HE as compared with HU but no significant difference as compared with controls. This is in contrast to data from the literature showing that ADMA levels are elevated in patients with essential hypertension. 28, 29 However, the limited sample sizes in our study likely compromises the power to detect small differences between groups.
Data from in vitro and animal experiments revealed that BP elevation and shear stress induces coagulation activation, 30, 31 and that the extent of coagulation activation is associated with the degree of target organ damage in patients with essential hypertension.
7,32-34 Also, malignant hypertension, a special form of hypertensive crisis characterized by thrombotic microangiopathy, is associated with enhanced thrombogenesis and fibrinolysis. 6 This is in line with our finding that PAP, a marker of activated fibrinolysis, and t-PA were elevated in patients with hypertensive emergencies. In contrast, there was only a trend toward higher PAI-1 levels in HE, which is consistent with observations made in malignant hypertension. 6 Different from the acute BP rise in hypertensive emergencies, patients with chronic essential hypertension appear to have impaired release of t-PA 35 and lowering of BP restores impaired t-PA synthesis and release. 36 The higher levels of t-PA Ag and active t-PA in HE could thus potentially reflect a different underlying mechanism as compared with chronic essential hypertension.
Increase in shear stress, angiotensin and stress hormones induces TF-mRNA in vitro. [37] [38] [39] These factors could contribute to the elevated levels of prothrombin fragment F 1 þ 2 in HE as compared with controls.
Platelet activation, as measured by P-selectin, 40 was also heightened in HE, which is in line with increased P-selectin levels in malignant hypertension. 6 There are several explanations for this finding. Platelets express angiotensin receptors on their surface 41 and infusion of angiotensin II leads to platelet activation. 42 Moreover, sympathetic activation, which is present in hypertensive emergencies, especially in pulmonary edema, and shear stress lead to platelet activation. 43 Interestingly, we found no significant difference in these parameters between patients with HU and normotensive controls. This is in contrast to numerous studies showing coagulation and platelet activation in essential hypertension. 44 However, our results are consistent with the results of van den Born et al., Inflammation, coagulation and fibrinolysis in hypertensive crisis U Derhaschnig et al where a subgroup comparable to HU showed as well no significant elevation in F 1 þ 2 levels as compared with normotensive controls. Again the limited sample size precludes detection of small differences.
Correlation analysis showed only weak correlation between SBP and markers of inflammation and coagulation in hypertensive urgencies and emergencies, which is rather related to differences between patient groups. It seems that coagulation and endo- thelial activation is not solely dependent on BP levels in hypertensive emergencies. Thus, it would be interesting to examine if patients will benefit from therapy with antihypertensive agents, like angiotensin-converting enzyme-I and ARB that additionally exert effects on coagulation and endothelial dysfunction. Further studies will be needed to clarify these questions.
LIMITATIONS
Because of our cross-sectional design, we cannot draw conclusions about cause-effect relationship and can only speculate about endothelial dysfunction as a pathogenetic factor for some of the alterations in biomarkers. Likewise, enhanced inflammation, platelet activation and coagulation activation could potentially contribute to target organ damage.
In conclusion, this prospective study revealed altered endothelial function, coagulation and platelet activation and fibrinolysis in hypertensive emergencies as compared with urgencies.
What is known about the topic
Hypertensive emergencies are possibly associated with activation of coagulation and inflammation. Clinical investigations are scarce.
What this study adds
Patients with hypertensive emergencies have elevated markers of thrombogenesis and fibrinolysis as compared with patients with urgencies.
Patients with hypertensive emergencies have elevated inflammatory parameters as compared with urgency patients. Inflammation, coagulation and fibrinolysis in hypertensive crisis U Derhaschnig et al
